IRIS Accounts Production v25.2.0.378 06710441 director 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067104412023-09-30067104412024-09-30067104412023-10-012024-09-30067104412022-09-30067104412022-10-012023-09-30067104412023-09-3006710441ns15:EnglandWales2023-10-012024-09-3006710441ns14:PoundSterling2023-10-012024-09-3006710441ns10:Director12023-10-012024-09-3006710441ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3006710441ns10:SmallEntities2023-10-012024-09-3006710441ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3006710441ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3006710441ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3006710441ns10:FullAccounts2023-10-012024-09-3006710441ns10:OrdinaryShareClass12023-10-012024-09-3006710441ns10:OrdinaryShareClass22023-10-012024-09-3006710441ns10:RegisteredOffice2023-10-012024-09-3006710441ns5:CurrentFinancialInstruments2024-09-3006710441ns5:CurrentFinancialInstruments2023-09-3006710441ns5:ShareCapital2024-09-3006710441ns5:ShareCapital2023-09-3006710441ns5:RetainedEarningsAccumulatedLosses2024-09-3006710441ns5:RetainedEarningsAccumulatedLosses2023-09-3006710441ns5:FurnitureFittings2023-10-012024-09-3006710441ns5:ComputerEquipment2023-10-012024-09-3006710441ns5:PlantMachinery2023-09-3006710441ns5:PlantMachinery2023-10-012024-09-3006710441ns5:PlantMachinery2024-09-3006710441ns5:PlantMachinery2023-09-3006710441ns10:OrdinaryShareClass12024-09-3006710441ns10:OrdinaryShareClass22024-09-3006710441ns5:RetainedEarningsAccumulatedLosses2023-09-3006710441ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-30
REGISTERED NUMBER: 06710441 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

OKRENT OSTEOPATHY LTD
OKRENT OSTEOPATHY LTD (REGISTERED NUMBER: 06710441)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


OKRENT OSTEOPATHY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTOR: Mr Leor Yehoshua Okrent





REGISTERED OFFICE: 307 Regents Park Road
London
N3 1DP





REGISTERED NUMBER: 06710441 (England and Wales)





ACCOUNTANTS: Syers McGill
9 Kerry Street
Horsforth
Leeds
West Yorkshire
LS18 4AW
Page 1
OKRENT OSTEOPATHY LTD (REGISTERED NUMBER: 06710441)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 950 971

CURRENT ASSETS
Debtors 5 137,011 141,631
Cash at bank 39,774 7,287
176,785 148,918
CREDITORS
Amounts falling due within one year 6 27,595 22,408
NET CURRENT ASSETS 149,190 126,510
TOTAL ASSETS LESS CURRENT
LIABILITIES
150,140
127,481

PROVISIONS FOR LIABILITIES 237 -
NET ASSETS 149,903 127,481

CAPITAL AND RESERVES
Called up share capital 7 8 8
Retained earnings 8 149,895 127,473
SHAREHOLDERS' FUNDS 149,903 127,481

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The notes form part of these financial statements

Page 2 continued...
OKRENT OSTEOPATHY LTD (REGISTERED NUMBER: 06710441)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 April 2025 and were signed by:





Mr Leor Yehoshua Okrent - Director


The notes form part of these financial statements

Page 3
OKRENT OSTEOPATHY LTD (REGISTERED NUMBER: 06710441)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Okrent Osteopathy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Computer equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 1 ) .

Page 4 continued...
OKRENT OSTEOPATHY LTD (REGISTERED NUMBER: 06710441)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023 22,944
Additions 225
At 30 September 2024 23,169
DEPRECIATION
At 1 October 2023 21,973
Charge for year 246
At 30 September 2024 22,219
NET BOOK VALUE
At 30 September 2024 950
At 30 September 2023 971

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Other debtors 137,011 141,631

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade creditors - 1
Tax 25,820 20,229
Directors' current accounts 35 438
Accrued expenses 1,740 1,740
27,595 22,408

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
6 Ordinary £1 6 8
2 Ordinary A £1 2 -
8 8

Page 5 continued...
OKRENT OSTEOPATHY LTD (REGISTERED NUMBER: 06710441)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


8. RESERVES
Retained
earnings
£   

At 1 October 2023 127,473
Profit for the year 78,422
Dividends (56,000 )
At 30 September 2024 149,895

9. RELATED PARTY DISCLOSURES

The company is related to Health Space 307 Ltd and ThreeBoys Ltd by way of common control.

During the year Health Space 307 Ltd invoiced the company £20,400 (2022: £20,400) in respect of rent. At the balance sheet date Health Space 307 Ltd owed the company £14,448 (2023: £19,066).

At the balance sheet date ThreeBoys Ltd Ltd owed the company £122,564 (2023: £122,564).

Page 6